INSERM
67Patents
35Active
67Granted
48Portfolio score
Filing activity: Nov 17, 1988 → Jun 9, 2020 · 7 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6227203A | Techniques for controlling abnormal involuntary movements by brain stimulation and drug infusion | Human Necessities | 207 | Expired |
| US6150091A | Direct molecular diagnosis of Friedreich ataxia | Emerging Cross-Sectional Technologies | 54 | Expired |
| US5374525A | Methods to determine predisposition to hypertension and association of variant angiotensinogen gene and hypertension | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5262405A | Method of improving bronchial mucus transport | Human Necessities | 28 | Expired |
| US6824972B2 | Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-&kgr;B) activation | Physics | 27 | Expired |
| US8003773B2 | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes | Human Necessities | 16 | Active |
| US7589110B2 | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear | Human Necessities | 12 | Expired |
| US5763168A | Method to determine predisposition to hypertension | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8604060B2 | Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases | Human Necessities | 10 | Active |
| US5105801A | Method and apparatus for improving the reproducibility and efficiency of the pressure waves generated by a shock wave generating apparatus | Physics | 10 | Expired |
| US7534867B1 | Purified mammalian Flt3 ligands; agonists; antagonists | Human Necessities | 8 | Expired |
| US6083753A | Soluble human prolactin receptors | Chemistry; Metallurgy | 6 | Expired |
| US9528086B2 | Recombinant bordetella strains | Emerging Cross-Sectional Technologies | 6 | Active |
| US5233980A | Apparatus and method for generating shockwaves for the destruction of targets, particularly in extracorporeal lithotripsy | Physics | 5 | Expired |
| US8858931B2 | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes | Human Necessities | 5 | Active |
| US7977098B2 | Antigenic binding patterns of norovirus to human histo-blood group antigens | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8026221B2 | Method, composition and kit for antigenic binding of norwalk-like viruses | Physics | 4 | Active |
| US4915094A | Apparatus for generating high frequency shock waves of which the electrical supply connection is disposed inside a tubular element, limiting or preventing electro-magnetic leakages | Physics | 4 | Expired |
| US6165727A | Method to determine predisposition to hypertension | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8236763B2 | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases | Human Necessities | 3 | Expired |
| US5741781A | Mercaptoalkanoyldipeptide compounds | Human Necessities | 3 | Expired |
| US7186558B2 | Keratinocytes obtained from embryonic stem cells of mammals | Chemistry; Metallurgy | 3 | Expired |
| US5085206A | System for initializing positions of target locating arm and device for firing focused shots | Human Necessities | 2 | Expired |
| US7537932B1 | Antibodies that bind purified mammalian FLT3 ligands | Human Necessities | 2 | Expired |
| US6759406B1 | Quaternary ammonium compounds | Emerging Cross-Sectional Technologies | 2 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.